Sandu Pharmaceuticals Hits 52-Week Low Amid Broader Sector Challenges

Sandu Pharmaceuticals has recently reached a 52-week low, closing at Rs 53.5 on January 13, 2025, and is currently just 0.93% away from this low point. In today's trading session, the stock outperformed its sector by 3.11%, despite a consecutive decline over the past two days, resulting in a total drop of -0.94% during this period. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past year, Sandu Pharmaceuticals has experienced a decline of -24.80%, contrasting with the Sensex's gain of 5.58% during the same timeframe. The broader trading sector has also faced challenges, with a decrease of -4.51%. This performance underscores the difficulties Sandu Pharmaceuticals is navigating in the current market landscape.